Dimethyl Fumarate (first-line oral treatment) is the methyl ester of fumaric acid, prescribed for multiple sclerosis. The risk or severity of adverse effects can be increased when Dimethyl ...

A phase II study has reported on efficacy of DMF in cutaneous lupus [1]. Evidence from patients with multiple sclerosis indicates that dimethyl fumarate (DMF), an electrophile, targets cellular ...